Pharmacokinetic interactions between carbamazepine and the traditional Chinese medicine Paeoniae Radix

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 4, 2002, Pages 532-535

  Chen, Lih Chi ^a,b   Chen, Yu Fang ^a   Chou, Mei Huei ^a   Lin, Ming Fang ^a   Yang, Ling Ling ^b,c   Yen, Kun Ying ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Carbamazepine; Interaction; Paeoniae Radix; Pharmacokinetic

Indexed keywords

CARBAMAZEPINE; PAEONIA RADIX; HERBACEOUS AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; EVALUATION; MALE; NONHUMAN; PROTEIN BINDING; RAT; STATISTICAL SIGNIFICANCE; ANIMAL; BLOOD; DRUG INTERACTION; HERB DRUG INTERACTION; METABOLISM; PAEONIA; PHYSIOLOGY; PLANT ROOT; SPRAGUE DAWLEY RAT;

ANIMALS; CARBAMAZEPINE; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; HERB-DRUG INTERACTIONS; MALE; PAEONIA; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036545411     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.532     Document Type: Article

References (17)

1. Chen L. C., Chen Y. F., Yang L. L., Chou M. H., Lin M. F., J. Clin. Pharm. Ther., 25, 125-129 (2000).
2. Brodie M. J., Dichter M. A., N. Engl. J. Med., 334, 168-175 (1996).
3. Kerr B. M., Sanins S. M., Thummel K. E., Levy R. H., Pharm. Res., 8, S239 (1991).
4. Kerr B. M., Thummel K. E., Wurden C. J., Klein S. M., Kroetz D. L., Gonzalez F. J., Levy R. H., Biochem. Pharmacol., 47, 1969-1979 (1994).
5. Sugaya A., Suzuki T., Sugaya E., Yuyama N., Yasuda K., Tsuda T., J. Ethnopharmacol., 33, 159-167 (1991).
6. Dezaki K., Kimura I., Miyahara K., Kimura M., Jpn. J. Pharmacol., 69, 281-284 (1995).
7. Kimura M., Kimura I., Nojima H., Jpn. J. Pharmacol., 37, 395-399 (1985).
8. Kimura M., Kimura I., Nojima H., Jpn. J. Pharmacol., 31 (Suppl.), 72 (1981).
9. Abdel-Hafez A. A., Meselhy M. R., Nakamura N., Hattori M., Watanabe H., Murakami Y., El-Gendy M. A., Mahfouz N. M., Mohamed T. A., Biol. Pharm. Bull., 22, 491-497 (1999).
10. Abdel-Hafez A. A., Meselhy M. R., Nakamura N., Hattori M., Watanabe H., Mohamed T. A., Mahfouz N. M., El-Gendy M. A., Chem. Pharm. Bull., 46, 1486-1487 (1998).
11. Riva R., Albani F., Contin M., Baruzzi A., Clin. Pharmacokinet., 31, 470-493 (1996).
12. Faigle J. W., Feldmann K. F., "Clinical Pharmacology of Antiepileptic Drugs," ed. by Schneider H., Janz D., Garnder-Thorpe C., Meinardi H., Sherwin H., Springer-Verlag, Berlin, 1975, pp. 159-165.
13. Levy R., Pitlick W., Troupin A., et al., Clin. Pharmacol. Ther., 17, 657-668 (1975).
14. Morselli P. L., Adv. Neurol., 11, 279-293 (1975).
15. Morselli P. L., Gerna M., Garattini S., Biochem. Pharmacol., 20, 2043-2047 (1971).
16. Morselli P. L., Monaco F., Gerna M., Recchia M., Riccio A., Epilepsia, 16, 759-764 (1975).
17. Kobayashi M., Ueda C., Aoki S., Tajima K., Tanaka N., Yamahara J., Yakugaku Zasshi, 110, 964-968 (1990).